{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:01:53Z","timestamp":1772809313812,"version":"3.50.1"},"reference-count":35,"publisher":"The Endocrine Society","issue":"8","funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1210\/jc.2019-00271","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:52:13Z","timestamp":1559130733000},"page":"3450-3461","source":"Crossref","is-referenced-by-count":26,"title":["Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment"],"prefix":"10.1210","volume":"104","author":[{"given":"Serge","family":"Ferrari","sequence":"first","affiliation":[{"name":"Geneva University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W","family":"Butler","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L","family":"Kendler","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D","family":"Miller","sequence":"additional","affiliation":[{"name":"Colorado Center for Bone Research, Lakewood, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Roux","sequence":"additional","affiliation":[{"name":"Paris Descartes University, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea T","family":"Wang","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Huang","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel B","family":"Wagman","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E Michael","family":"Lewiecki","sequence":"additional","affiliation":[{"name":"New Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"2019062707401788500_bib1","volume-title":"Bone Health and Osteoporosis. A Report of the Surgeon General","year":"2004"},{"issue":"6","key":"2019062707401788500_bib2","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00198-015-3088-z","article-title":"Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS)","volume":"26","author":"Abimanyi-Ochom","year":"2015","journal-title":"Osteoporos Int"},{"issue":"12","key":"2019062707401788500_bib3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"issue":"18","key":"2019062707401788500_bib4","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"2019062707401788500_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1210\/jc.2013-3461","article-title":"The impact of nonhip nonvertebral fractures in elderly women and men","volume":"99","author":"Bliuc","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019062707401788500_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00198-010-1267-5","article-title":"Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US","volume":"22","author":"Pike","year":"2011","journal-title":"Osteoporos Int"},{"issue":"12","key":"2019062707401788500_bib7","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00198-012-1935-8","article-title":"Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)","volume":"23","author":"Roux","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"2019062707401788500_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2474-3-11","article-title":"The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women","volume":"3","author":"Adachi","year":"2002","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"2019062707401788500_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2019062707401788500_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bonr.2016.07.005","article-title":"Hospitalizations for osteoporosis-related fractures: economic costs and clinical outcomes","volume":"5","author":"Weycker","year":"2016","journal-title":"Bone Rep"},{"issue":"9041","key":"2019062707401788500_bib11","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"18","key":"2019062707401788500_bib12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"2019062707401788500_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"14","key":"2019062707401788500_bib14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"2019062707401788500_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"24","key":"2019062707401788500_bib16","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"2019062707401788500_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S8756-3282(02)00946-8","article-title":"Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience","volume":"32","author":"Sorensen","year":"2003","journal-title":"Bone"},{"issue":"7","key":"2019062707401788500_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2019062707401788500_bib19","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00198-015-3179-x","article-title":"Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years","volume":"26","author":"Ferrari","year":"2015","journal-title":"Osteoporos Int"},{"issue":"1","key":"2019062707401788500_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12891-017-1520-6","article-title":"Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study","volume":"18","author":"Adachi","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"2019062707401788500_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women","volume":"332","author":"Cummings","year":"1995","journal-title":"N Engl J Med"},{"issue":"8","key":"2019062707401788500_bib22","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00198-011-1840-6","article-title":"Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women","volume":"23","author":"Pfeilschifter","year":"2012","journal-title":"Osteoporos Int"},{"issue":"3","key":"2019062707401788500_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.1472","article-title":"Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures","volume":"27","author":"Austin","year":"2012","journal-title":"J Bone Miner Res"},{"key":"2019062707401788500_bib24","author":"Ferrari"},{"issue":"2","key":"2019062707401788500_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bone.2013.07.011","article-title":"Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab","volume":"56","author":"Genant","year":"2013","journal-title":"Bone"},{"issue":"7","key":"2019062707401788500_bib26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019062707401788500_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X16670154","article-title":"Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"7","key":"2019062707401788500_bib28","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/jbmr.2480","article-title":"Sustained modeling-based bone formation during adulthood in cynomolgus monkeys may contribute to continuous BMD gains with denosumab","volume":"30","author":"Ominsky","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2019062707401788500_bib29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","article-title":"Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial","volume":"25","author":"Schwartz","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019062707401788500_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"van Geel","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2019062707401788500_bib31","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"2019062707401788500_bib32","author":"Watts"},{"issue":"2","key":"2019062707401788500_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM Trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019062707401788500_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00223-018-0404-6","article-title":"Bone loss after romosozumab\/denosumab: effects of bisphosphonates","volume":"103","author":"Horne","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"2019062707401788500_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/jc.2019-00271\/28693619\/jc.2019-00271.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/8\/3450\/28874680\/jc.2019-00271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T06:16:58Z","timestamp":1569392218000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/8\/3450\/5497103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,5,24]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-00271","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735836716.793569334","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,5,24]]}}}